logo
Select company
Select metric
$ -126.81MNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
10
Sector
7
Industry
6
History
3
$ 16.95Close
$ 3.93 - $ 21.42 52-Week Range
Ticker Information

Ticker

URGN

Company Name

UROGEN PHARMA LTD

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

UROGEN PHARMA LTD - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

URGN - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ -126.81M
3/31/2025$ -27.15M
12/31/2024$ 77.24M
9/30/2024$ 5.87M
6/30/2024$ 199.85M
3/31/2024$ 94.91M
12/31/2023$ 39.6M
9/30/2023$ 90.63M
6/30/2023$ -60.56M
3/31/2023$ -68.57M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • UROGEN PHARMA LTD's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ -40.88M.
  • Over the past 5 years, UROGEN PHARMA LTD's average CF - Chg. Cash has been $ 15.8M.
  • The median CF - Chg. Cash for UROGEN PHARMA LTD during this period was $ 12.33M
  • UROGEN PHARMA LTD reached its highest CF - Chg. Cash over the past 5 years at $ 199.85M.
  • The lowest CF - Chg. Cash recorded by UROGEN PHARMA LTD in the same timeframe $ -126.81M

UROGEN PHARMA LTD's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
NRIX : NURIX THERAPEUTICS INC $ -20.54MSNDX : SYNDAX PHARMACEUTICALS INC $ 3.24MGYRE : GYRE THERAPEUTICS INC $ 20.39MCRMD : CORMEDIX INC $ 130.77MNAGE : NIAGEN BIOSCIENCE INC $ 32.59MZYME : ZYMEWORKS INC $ 27.29MPHAT : PHATHOM PHARMACEUTICALS INC $ -126.67MTBPH : THERAVANCE BIOPHARMA INC $ 235.58MWVE : WAVE LIFE SCIENCES LTD $ 54.58MKURA : KURA ONCOLOGY INC $ 36.77M

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

URGN - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -126.81M

Minimum

Jun 30, 2025

$ 199.85M

Maximum

Jun 30, 2024

$ 15.8M

Average

$ 12.33M

Median

CF - Chg. Cash Benchmark Analysis

The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.18M with a standard deviation of $ 44.92M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -136.09M
max$ 137.58M
average$ 1.18M
median$ 115.89K
std$ 44.92M